• home
  • the advantage
  • about us
    • key facts
    • where we are
    • where we invest
    • management team
    • funds
  • investments
    • focus
      • prevention & nutraceuticals
      • medical foods OTC, Rx
      • enabling technologies
      • brands & channels
      • diagnostics
    • CEOs
    • portfolio
    • criteria
    • process
  • news
  • your business
  • careers
  • contact us
    • the bahamas
    • united kingdom
    • switzerland
    • new zealand

investments

criteria

Geography
  • Global
 
Development stage
  • Biopharmaceutical company; proof of concept
  • Consumer product; revenue generating
 
Operational profile
  • Talented management team
  • Established IP position and/or strong brand potential
 
Investment philosophy
  • We are an active investor and prefer to take a leading position during fund raising
  • We will co-invest in the right opportunities
  • We prefer to be active in the Board of Directors
 
Security types
  • Equity
  • Convertible loans
 
Investment amount
  • Up to $50 million over the investment lifetime
  • No limit for buy-outs
  • Preferred initial investment of $8-10 million
Neill Moray Mackenzie, CMP Therapeutics
Neill Moray Mackenzie, CMP Therapeutics:
"Inventages has been extremely supportive of CMP Therapeutics since its inception." More...
Terms Print Top
© 2012 Inventages